|
| Home : Supreme Closes Second Tranche of Private Placement for Aggregate Proceeds of $4.34m and Secures Additional Long Term Supply Agreement |
|
Jul 16
2016 |
Supreme Closes Second Tranche of Private Placement for Aggregate Proceeds of $4.34m and Secures Additional Long Term Supply Agreement |
|
TORONTO, ONTARIO--(Marketwired - July 15, 2016) - Supreme Pharmaceuticals Inc. (the "Company" or "Supreme") (CSE:SL)(OTC PINK:SPRWF) is pleased to announce it has closed the second tranche of its previously announced non-brokered private placement (the "Financing") for proceeds of $723,250 and aggregate proceeds from both tranches of $4,339,130. Upon closing, the company issued 1,808,125 units (each a "Unit") at a price of $0.40 per Unit. Each Unit consists of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each warrant is exercisable for one Common Share of the corporation at a price of $0.50 for a period of three years from closing. |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=2142787&sourceType=3 |
| |
|
Related News
|
» Everton Announces the Closing of the 2nd Tranche of its Non-Brokered Private Placement of $425,000
» Potomac Nationals Military Appreciation Day Honors Soldiers and Veterans
|
|
|
